Literature DB >> 6456561

Studies of the staphylococcal causation of toxic shock syndrome.

W A Altemeier, S Lewis, P M Schlievert, H S Bjornson.   

Abstract

The data presented in this study indicate that the Staphylococcus aureus is related casually to the toxic shock syndrome and that the dominant phage type was 29. This type has occurred singly as well as in combination with phage type 52 and some other group I phage types. The 29, 52 complex was present in approximately two-thirds of a series of 159 isolates of Staphylococcus aureus obtained from patients with toxic shock syndrome, while another fourth was nontypable. In further support of this concept was the evidence that 94.1 per cent of the isolates of the 29, 52 phage complex tested were capable of producing pyrogenic exotoxin C. These results gave confirmatory evidence of the etiologic importance of this phage type complex of Staphylococcus aureus. The high percentage of 25.8 per cent nontypable isolated has remained unexplained, and this is suggestive of the possibility that another important phage type may be present but obscure, since 83 per cent were shown to be capable of producing pyrogenic C toxin. The data reported also indicated that the current activity of this phage type is another manifestation of the versatility of Staphylococcus aureus and its ability to produce different pathogenic strains capable of causing different or new infections in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456561

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  11 in total

1.  Reemergence of staphylococcal toxic shock syndrome in the United States since 2000.

Authors:  Philip M Tierno
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Sequence analysis of the Staphylococcus aureus srrAB loci reveals that truncation of srrA affects growth and virulence factor expression.

Authors:  Alexa A Pragman; Lisa Herron-Olson; Laura C Case; Sara M Vetter; Evan E Henke; Vivek Kapur; Patrick M Schlievert
Journal:  J Bacteriol       Date:  2007-08-10       Impact factor: 3.490

3.  Toxic Shock Syndrome: A Family Physician's Perspective.

Authors:  D L Myhre
Journal:  Can Fam Physician       Date:  1982-10       Impact factor: 3.275

4.  Characterization of staphylococci from patients with toxic shock syndrome.

Authors:  B Aliu; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 5.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 6.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

7.  Production of toxic-shock-associated protein(s) in Staphylococcus aureus strains isolated from 1956 through 1982.

Authors:  P S Hayes; L M Graves; J C Feeley; G A Hancock; M L Cohen; A L Reingold; C V Broome; A W Hightower
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

Review 8.  Toxic-shock syndrome: a commentary and review of the characteristics of Staphylococcus aureus strains.

Authors:  P J Chesney
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

Review 9.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 10.  Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis.

Authors:  Patrick M Schlievert; Kristi L Strandberg; Ying-Chi Lin; Marnie L Peterson; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.